FDA Study Of Rx TV Ads Should Recruit Participants More Broadly, Firms Say
Executive Summary
Industry is recommending that FDA modify the recruitment strategies for its study of Rx TV ads and represent more diseases in sample ads shown to participants in order to facilitate more comprehensive and efficient data collection
You may also be interested in...
FDA Expands Advisory Cmte. Disclosures As Congress Directs Conflict Reductions
FDA's draft guidance on the procedure for disclosing conflicts of interest will extend the agency's disclosure policy to cover all advisory committee members
DTC Fines May Be More Useful To Advertising Opponents Than An FDA Ban
Opponents of direct-to-consumer television ads will be better off with FDA having authority to fine companies for false and misleading television ads than they would have been if the agency was given the power to simply ban such ads, according to Scott Lassman, former Senior Assistant General Counsel at Pharmaceutical Research and Manufacturers of America
Rx TV Ads To Get FDA Study On How Visual Cues May Distract From Audio Risks
Data collection in an FDA study of how the audio, visual and textual components of a television ad affect a viewer's intake of information and perception of a drug's risks and benefits is expected to begin in May 2008